GEN News Highlights: Aug 24, 2011

Department of Defense Backs Two Lupus Projects with $2.3M

(Page 1 of 1)

    The U.S. Department of Defense (DoD) is separately granting two researchers $2.3 million to advance their respective lupus research. The money comes from DoD’s Congressionally Directed Peer Reviewed Medical Research Program (PRMRP).

    I-Cheng Ho, M.D., Ph.D., associate physician at Brigham and Women’s Hospital, received $1.2 million. The work will examine a protein called Ets1 to determine if it can counteract the disease process of lupus; it is believed that the function of Ets1 may be impaired in people with lupus.

    Trine Jorgensen, Ph.D., assistant staff, department of immunology, Cleveland Clinic Foundation was awarded $1.1 million. The research will study why females are disproportionately affected by lupus; nine out of ten people with lupus are reportedly female. Dr. Jorgensen’s studies will explore the role of a population of immunosuppressive cells in the development of lupus and analyze related mechanisms of disease suppression as it may occur in males.

    To date, $11.8 million has reportedly been awarded to lupus researchers through the PRMRP. Due to the changing demographics of the military population, there is an ever-increasing prevalence of lupus in military.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll